Damiano Regazzoli, MD

First-in-man Percutaneous LAA Closure With an Amplatzer Amulet and TriGuard Embolic Protection Device in a Patient With LAA Thrombus

03/30/2017

Francesca Del Furia , MD;

Francesco Giannini , MD;

Antonio Colombo , MD;

Matteo Montorfano , MD;

Azeem Latib , MD, BCh, MBBCh;

Antonio Mangieri , MD;

Damiano Regazzoli , MD;

Richard J. Jabbour , MD;

We report on first-in-man percutaneous LAA closure with the Amplatzer Amulet device in the presence of LAA thrombus using the TriGuard EPD as a cerebral protection device.

We report on first-in-man...

03/30/2017

Journal of Invasive Cardiology

Original Contribution

A Comparison Between First-Generation and Second-Generation Transcatheter Aortic Valve Implantation (TAVI) Devices: A Propensity-Matched Single-Center Experience

05/01/2016

Fabrizio Monaco , MD;

Pietro Spagnolo , MD;

Ottavio Alfieri , MD;

Akihito Tanaka , MD;

Francesco Giannini , MD;

Filippo Figini , MD;

Azeem Latib , MD, BCh, MBBCh;

Damiano Regazzoli , MD;

Antonio Mangieri , MD;

Marco B. Ancona , MD;

Antonio Colombo , MD;

Alessandro Sticchi , MD;

Stefano Stella , MD;

Eustachio Agricola , MD;

Alaide Chieffo , MD;

Nicola Buzzatti , MD;

Matteo Montorfano , MD;

Hiroyoshi Kawamoto , MD;

Neil Ruparelia , DPhil, MRCP, MD;

The aim of this study was to investigate the impact of second-generation (2G) devices in comparison to first-generation (1G) devices with regard to procedural and short-term clinical outcomes.

The aim of this study was to...

05/01/2016

Journal of Invasive Cardiology

Original Contribution

Ultra-Low Contrast Percutaneous Coronary Intervention to Minimize the Risk for Contrast-Induced Acute Kidney Injury in Patients With Severe Chronic Kidney Disease

03/14/2019

Davide Maccagni , RT;

Damiano Regazzoli , MD;

Satoru Mitomo , MD;

Barbara Bellini , MD;

Ozan M. Demir , MBBS, MD, MRCP;

Alessandra Laricchia , MD;

Enrico Poletti , MD;

Daisuke Hachinohe , MD;

Antonio Colombo , MD;

Lorenzo Azzalini , MD, PhD, MSc;

We aimed to evaluate the feasibility of an ultra-low contrast volume percutaneous coronary intervention protocol in patients with severe chronic kidney disease.

We aimed to evaluate the...

03/14/2019

Journal of Invasive Cardiology

Comparing the Safety and Effectiveness of Five Leading New-Generation Devices for Transcatheter Aortic Valve Implantation: Twelve-Month Results From the RISPEVA Study

05/01/2021

Martino Pepe , MD, PhD;

Alberto Morello , MD;

Antonio L. Bartorelli , MD;

Carmen Spaccarotella , MD;

Michele Cimmino , MD;

Anna Sonia Petronio , MD;

Luca Testa , MD, PhD;

Maurizio Tespili , MD;

Alessandro Iadanza , MD;

Arturo Giordano , MD, PhD;

Nicola Corcione , MD;

Paolo Ferraro , MD;

Giacomo Frati , MD, MSc;

Giuseppe G.L. Biondi-Zoccai , MD, PhD;

Sergio Berti , MD;

Enrico Romagnoli , MD, PhD;

Damiano Regazzoli , MD;

To learn more about the comparative effectiveness and safety of contemporary TAVI devices, we queried data from the national Italian TAVI registry comparing features, procedural details, and 12-month outcomes of Acurate Neo, Evolut Pro/R,...

To learn more about the...

05/01/2021

Journal of Invasive Cardiology